Xie Yihui, Shi Weimin, Yin Wenhao, Mei Xingyu
Department of Dermatology, The Affiliated Hospital of Jiaxing University, The First Hospital of Jiaxing, Jiaxing, Zhejiang, China.
Department of Dermatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
J Cosmet Dermatol. 2025 Feb;24(2):e16715. doi: 10.1111/jocd.16715. Epub 2024 Dec 8.
A 308 nm excimer light is an effective treatment for vitiligo, with fewer treatment times, rapid obvious effects, relatively complete pigment recovery, good patient compliance, and safe and effective treatment for children. The disadvantage of this treatment is that some patients have a plateau during which the skin lesion reduction rate slows down or stalls after multiple treatments.
Treatment data were collected from all vitiligo patients in the Dermatology Department, distinguishing between those who underwent 308 nm excimer light treatment alone and those who received a combination of 308 nm excimer light and 2940 erbium laser treatment.
Of the 104 patients, 60 were treated with 308 nm excimer light only, and 44 were treated with a combination of a 2940 erbium laser and 308 nm excimer light. In contrast to the treatment of 308 nm excimer light alone, the combined treatment of the 2940 erbium laser and 308 nm excimer light significantly increased the speed and degree of repigmentation in vitiligo.
Our study demonstrates that the combination of 308 nm excimer light and 2940 nm erbium laser treatment can improve the treatment response for vitiligo, decrease the occurrence of treatment plateaus associated with 308 nm excimer light, and improve efficacy.
ChiCTR2000036712 (24/08/2020).
308纳米准分子光是治疗白癜风的一种有效方法,治疗次数较少,效果迅速明显,色素恢复相对完全,患者依从性好,对儿童治疗安全有效。这种治疗方法的缺点是,一些患者在多次治疗后会出现平台期,在此期间皮损减少率减缓或停滞。
收集皮肤科所有白癜风患者的治疗数据,区分仅接受308纳米准分子光治疗的患者和接受308纳米准分子光与2940铒激光联合治疗的患者。
104例患者中,60例仅接受308纳米准分子光治疗,44例接受2940铒激光与308纳米准分子光联合治疗。与单独使用308纳米准分子光治疗相比,2940铒激光与308纳米准分子光联合治疗显著提高了白癜风色素沉着的速度和程度。
我们的研究表明,308纳米准分子光与2940纳米铒激光联合治疗可改善白癜风的治疗反应,减少与308纳米准分子光相关的治疗平台期的发生,并提高疗效。
ChiCTR2000036712(2020年8月24日)。